See how continuous glucose monitors replace painful finger sticks, deliver real-time alerts, and help prevent dangerous highs ...
Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...
Amram Kahn, MD, discusses shifting diabetes care from A1c targets to early GLP-1–driven cardiometabolic risk reduction.
PharmaSens AG, a Swiss developer of next-generation insulin patch pump systems, announced that the Journal of Diabetes Science and Technology (JDST) has published data from the first clinical study ...
Are you at risk of diabetes? Read on to know what the ideal blood sugar level is after 40 and how you can manage it ...
The burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective ...
Preclinical research on Caliway's fat reduction drug candidate CBL-514 in combination with GLP-1R-based weight-loss therapies has been selected for presentation at the American Diabetes Association's ...
Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...
Amarin Corporation plc (NASDAQ: AMRN) ("Amarin"), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...
The group’s Valuing the Invaluable 2026 report found that 4.3 million Floridians caring for adults contribute roughly 4.1 ...
A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results